Beranda532523 • BOM
add
Biocon Ltd
Tutup sebelumnya
₹359,20
Rentang hari
₹358,30 - ₹366,50
Rentang tahun
₹231,35 - ₹395,65
Kapitalisasi pasar
416,88Â M INR
Volume Rata-Rata
180,71Â rb
Rasio P/E
30,34
Hasil dividen
0,14%
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(INR) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 35,90Â M | 3,70% |
Biaya operasional | 21,42Â M | 8,03% |
Laba bersih | -160,00Â jt | -112,74% |
Margin laba bersih | -0,45 | -112,40% |
Penghasilan per saham | -0,19 | -115,53% |
EBITDA | 6,78Â M | -6,58% |
Tarif pajak efektif | 72,46% | — |
Neraca
Total aset
Total liabilitas
(INR) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 26,50Â M | -30,00% |
Total aset | 571,28Â M | 4,67% |
Total liabilitas | 304,08Â M | 0,36% |
Total ekuitas | 267,20 M | — |
Saham yang beredar | 1,23 M | — |
Harga terhadap nilai buku | 2,11 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 1,56% | — |
Arus Kas
Perubahan kas bersih
(INR) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | -160,00Â jt | -112,74% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Didirikan
1978
Kantor pusat
Situs
Karyawan
16.315